Karyopharm Therapeutics I... (KPTI)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.55

-21.57%

Pre-market Dec 16, 2024, 04:19 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	146.03M	157.07M	209.82M	108.08M	40.89M	30.34M	1.60M	154.00K	250.00K	229.00K	387.00K	634.00K	152.00K
Cost of Revenue	4.94M	5.21M	3.40M	2.71M	2.41M	161.37M	107.27M	86.94M	97.74M	60.13M	28.45M	14.10M	-
Gross Profit	141.09M	151.86M	206.42M	105.38M	38.49M	-131.04M	-105.67M	-86.78M	-97.49M	-59.90M	-28.07M	-13.46M	152.00K
Operating Income	-129.54M	-142.20M	-98.27M	-171.85M	-189.28M	-179.88M	-130.54M	-110.73M	-119.08M	-75.85M	-33.95M	-15.89M	-10.31M
Interest Income	10.94M	2.36M	582.00K	2.82M	5.42M	4.03M	1.70M	1.28M	897.00K	97.00K	3.00K	2.00K	-
Pretax Income	-142.78M	-164.92M	-123.82M	-195.96M	-199.55M	-178.38M	-128.92M	-109.44M	-118.18M	-75.78M	-33.95M	-15.89M	-10.31M
Net Income	-143.10M	-165.29M	-124.09M	-196.27M	-199.59M	-178.41M	-128.98M	-109.58M	-118.18M	-75.78M	-33.95M	-15.89M	-10.31M
Selling & General & Admin	131.88M	145.40M	143.85M	126.42M	105.42M	48.85M	24.87M	23.95M	21.58M	15.95M	5.88M	2.43M	1.84M
Research & Development	138.75M	148.66M	160.84M	150.81M	122.34M	161.37M	107.27M	86.94M	97.74M	60.13M	28.45M	14.10M	8.62M
Other Expenses	-	-83.00K	-85.00K	206.00K	-50.00K	-33.00K	-81.00K	10.00K	-2.00K	-27.00K	-	-	-
Operating Expenses	270.63M	294.06M	304.69M	277.23M	227.76M	210.22M	132.14M	110.89M	119.33M	76.08M	34.34M	16.52M	10.46M
Interest Expense	23.82M	25.00M	26.05M	27.14M	15.65M	2.49M	-	-	-	1K	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	275.57M	299.28M	308.09M	279.94M	230.17M	210.22M	132.14M	110.89M	119.33M	76.08M	34.34M	16.52M	10.46M
Income Tax	323.00K	369.00K	268.00K	309.00K	40.00K	26.00K	63.00K	139.00K	-895.00K	-69.00K	-3.00K	-2.00K	-
Shares Outstanding (Basic)	114.22M	81.87M	75.22M	72.04M	61.96M	56.78M	45.90M	37.52M	35.62M	31.14M	6.07M	2.39M	1.00M
Shares Outstanding (Diluted)	114.22M	81.87M	75.22M	72.04M	61.96M	56.78M	45.90M	37.52M	35.62M	31.14M	6.07M	2.39M	1.00M
EPS (Basic)	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92	-3.32	-2.43	-5.59	-6.64	-10.27
EPS (Diluted)	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92	-3.32	-2.43	-5.59	-6.64	-10.27
EBITDA	-118.42M	-139.31M	-96.98M	-167.85M	-182.93M	-175.15M	-128.21M	-108.72M	-118.44M	-75.45M	-33.80M	-15.77M	-10.23M
Depreciation & Amortization	530.00K	621.00K	789.00K	972.00K	974.00K	735.00K	713.00K	717.00K	634.00K	323.00K	144.00K	122.00K	83.00K